EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of nucleosome structure on CRISPR/Cas9 fidelity

Christopher R Handelmann, Maria Tsompana, Ram Samudrala, Michael J Buck iD

Nucleic Acids Research · 2023

DOI: 10.1093/nar/gkad021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Christopher R Handelmann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14203, USA. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Nucleosomes. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NLM NIH HHS, NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clustered regularly interspaced short palindromic repeats (CRISPR) Cas system is a powerful tool that has the potential to become a therapeutic gene editor in the near future. Cas9 is the best studied CRISPR system and has been shown to have problems that restrict its use in therapeutic applications. Chromatin structure is a known impactor of Cas9 targeting and there is a gap in knowledge on Cas9’s efficacy when targeting such locations. To quantify at a single base pair resolution how chromatin inhibits on-target gene editing relative to off-target editing of exposed mismatching targets, we developed the gene editor mismatch nucleosome inhibition assay (GEMiNI-seq). GEMiNI-seq utilizes a library of nucleosome sequences to examine all target locations throughout nucleosomes in a single assay. The results from GEMiNI-seq revealed that the location of the protospacer-adjacent motif (PAM) sequence on the nucleosome edge drives the ability for Cas9 to access its target sequence. In addition, Cas9 had a higher affinity for exposed mismatched targets than on-target sequences within a nucleosome. Overall, our results show how chromatin structure impacts the fidelity of Cas9 to potential targets and highlight how targeting sequences with exposed PAMs could limit off-target gene editing, with such considerations improving Cas9 efficacy and resolving current limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNucleosomesGene EditingGene Library

Substanzen

Nucleosomes

Autor:innen und Institutionen

  • Department of Biochemistry, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14203, USA.
  • Department of Biomedical Informatics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY 14203, USA.

ORCID-Profile: Michael J Buck

Förderung

  • NLM NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • NCATS NIH HHS
  • National Institute of General Medical Sciences
  • National Library of Medicine
  • National Institutes of Health

Zitieren

APA

Handelmann, C. R., Tsompana, M., Samudrala, R., & Buck, M. J. (2023). The impact of nucleosome structure on CRISPR/Cas9 fidelity. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad021

Vancouver

Handelmann CR, Tsompana M, Samudrala R, Buck MJ. The impact of nucleosome structure on CRISPR/Cas9 fidelity. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad021

BibTeX
@article{Handelmann2023,
  author = {Handelmann, Christopher R and Tsompana, Maria and Samudrala, Ram and Buck, Michael J},
  title = {The impact of nucleosome structure on CRISPR/Cas9 fidelity},
  journal = {Nucleic Acids Research},
  year = {2023},
  doi = {10.1093/nar/gkad021}
}
Kostenlos starten →